NASDAQ
Athira Pharma, Inc. (ATHA) has a free cash flow growth of -7.76% as of Friday, May 29, 2026. This represents a 83.33% increase compared to its 12-month average of -46.58%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.